Fighting a Smarter War Against Cancer:
Personalized Medicine & the Cure for Cancer
February 17, 2010 | 2-6:30pm
A symposium for medical professionals, researchers and patient advocates
About | Agenda | Schafer Lecture | Speakers | Listen to Podcasts
12 min, 39 seconds
Director, Ruesch Center for the Cure of GI Cancers
Associate Director for Clinical Research, Georgetown Lombardi Comprehensive Cancer CenterJohn L. Marshall, MD, is a global leader in the research and development of drugs for colon cancer and other GI cancers. He is the principal investigator of over 150 clinical trials, at the local as well as national levels. Marshall is the clinical director of oncology for Georgetown University Hospital, associate director for clinical research of the Georgetown Lombardi Comprehensive Cancer Center, and chief of the Division of Hematology/Oncology. He is widely published in the field of clinical oncology, reviews manuscripts for eight journals, and holds peer-reviewed grants from the National Institutes of Health.
Marshall’s own research focuses on the development of a novel vaccine for the treatment of advanced colon cancer. For over a decade, he has directed Lombardi's Developmental Therapeutics Program while also maintaining his regular clinical practice. Seeing about 60 patients each week, Marshall specializes in cancers of the GI tract at all stages of the disease.
An outspoken advocate for clinical research, Marshall founded the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Lombardi in 2009. Its mission is to realize the dream of individualized curative therapies through research, care and advocacy. The Center, directed by Marshall, combines expertise in molecular medicine, translational research and a patient-centered philosophy.
